LGM Pharma Expands U.S. CDMO Capacity and Navigates Reshoring, Supply-Chain Risks

24/7 Biopharma had the opportunity to sit down for a long-form interview about the state of the CDMO industry with Hamilton Lenox, Chief Commercial Officer, and Matt Grazioli, Senior Marketing Manager, of LGM Pharma. The discussion touched on LGM’s recent facility expansions, shifting market demands in the CDMO segment, and how the company is responding to the uncertain state of the global economy, among various other topics.

LATEST VIDEO

Latest news

31st August 2026

Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases

31st August 2026

HAS Group announces successful Swissmedic inspection of the new ADC Suite at Cerbios-Pharma SA

28th August 2026

Neuland Laboratories expands Sterile API Manufacturing capacity

27th August 2026

CPHI Pharma Awards finalists announced across innovation, sustainability and leadership categories

27th August 2026

Centrix Pharma Solutions and University of Sussex partner to advance data-driven pharmaceutical development

27th August 2026

Symbiosis strengthens commercial team with appointment of Jay Chima

26th August 2026

Centrix Pharma Solutions and University of Sussex partner to advance data-driven pharmaceutical development

26th August 2026

Lonza Appoints Samanta Cimitan as Chief Commercial Officer

24th August 2026

WuXi XDC Delivers Strong First Half 2026 Performance, with Improving Margins and Profitability Further Strengthening Global ADC/XDC CRDMO Leadership

21st August 2026

Siegfried delivers profitable growth and confirms outlook

20th August 2026

Lupin and Tenpoint Therapeutics Announce Strategic Partnership to Commercialize YUVEZZI™ in the European Union, the United Kingdom, Switzerland, Norway, and Iceland

This week’s featured articles

Navigating Complexity: Industry Leaders on Bioprocessing, Manufacturing and Partnership Models

A woman’s view from the HAS Group

Breaking Barriers: Women Scientists Rising to Leadership in Pharma

Strategic Growth in Biologics Manufacturing: Insights from Lonza's Acquisition of the Vacaville Site

Grifols’ supply chain strategy offers lessons beyond saline

Partnered with top industry events and organisations